Aberrant accumulation of interleukin-10-secreting neutrophils in TRAF2-deficient mice.
Aberrant accumulation of interleukin-10-secreting neutrophils in TRAF2-deficient mice.
复制标题
TRAF2 缺陷小鼠中分泌白细胞介素 10 的中性粒细胞异常积累。
DOI:
10.1038/icb.2012.22
复制
发表时间:
2012
影响因子:
4
通讯作者:
Piao JH
中科院分区:
文献类型:
--
作者:
Yoshikawa;S.;Oh-hora;M.;Miyake;K.;Li;L.;Ohta;T.;Adachi;T.;Horiguchi;K.;Kawano;Y.;Karasuyama;H.;Piao JH
Highly coordinated expression of inflammatory and anti‐inflammatory cytokines is crucial for maintaining homeostasis of the gut that is constantly exposed to large amounts of commensal bacteria. We have previously reported that tumor necrosis factor (TNF) receptor‐associated factor (Traf)2−/−mice spontaneously develop severe colitis and that the development of colitis largely depends on TNFα‐dependent apoptosis of colonic epithelial cells. However, the detailed molecular mechanisms underlying the immunological disorders ofTraf2−/−mice are not fully understood. Here we show that interleukin (IL)‐10‐secreting neutrophils accumulated in peripheral blood and bone marrow (BM) cells fromTraf2−/−mice compared with those from wild‐type mice. Treatment ofTraf2−/−mice with neutralizing antibody against TNFα or crossingTraf2−/−mice withTnfr1−/−mice reduced the percentages of IL‐10‐secreting neutrophils, suggesting that the development of IL‐10‐secreting neutrophils largely depended on TNFα signals. Moreover, stimulation of BM cells from wild‐type mice with lipopolysaccharide and Pam3CS(K)4, a ligand for Toll‐like receptor 4 and 2, respectively, induced differentiation of BM cells into IL‐10‐secreting neutrophils. These results suggest that the development of IL‐10‐secreting neutrophils is not restricted toTraf2−/−mice, but could be generalized to wild‐type mice under certain conditions such as inflammation. Finally, combined treatment ofTraf2−/−mice with neutralizing antibodies against TNFα and IL‐10, but not each antibody alone, substantially ameliorated colitis and prolonged survival. Together, abrogation of immunosuppressive conditions mediated by IL‐10‐secreting neutrophils might be an alternative strategy to treat chronic inflammatory diseases at least under certain conditions.